• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病健康评估问卷(SHAQ)巴西版的跨文化调适与验证

Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

作者信息

Rocha Luiza F, Marangoni Roberta G, Sampaio-Barros Percival D, Levy-Neto Mauricio, Yoshinari Natalino H, Bonfa Eloisa, Steen Virginia, Kowalski Sergio C

机构信息

Disciplina de Reumatologia, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Arnaldo, 455 - 3º, Andar, Cerqueira César, São Paulo, São Paulo, Brazil, 01246-903.

出版信息

Clin Rheumatol. 2014 May;33(5):699-706. doi: 10.1007/s10067-013-2370-8. Epub 2013 Aug 22.

DOI:10.1007/s10067-013-2370-8
PMID:23975361
Abstract

The Scleroderma Health Assessment Questionnaire (SHAQ) is a feasible multisystem specific tool that has been extensively used as an additional assessment for systemic sclerosis (SSc). The aim of this study is to cross-culturally adapt and validate the Brazilian version of the SHAQ. Construct validity was assessed based on the correlations between SHAQ and both the Medical Outcomes Survey Short Form 36 version 2 (SF-36v2™) and the Health Assessment Questionnaire Disability Index (HAQ-DI). The correlation between the SHAQ and disease severity was assessed by Spearman's correlation coefficient. The reproducibility of the SHAQ was evaluated by the intraclass correlation coefficient (ICC). Among the 151 consecutive outpatients evaluated, 59 % had limited SSc subtype. The overall disease severity visual analog scale (VAS) of the SHAQ was statistically significantly correlated to HAQ-DI, pain VAS, and the SF-36v2™ physical component summary score (r = 0.595, r = 0.612, and r = -0.582, respectively; p < 0.001). Further analysis of all SF-36v2™ components revealed statistically significant correlations between overall disease severity VAS and bodily pain (r = -0.621, p < 0.001), vitality (r = -0.544, p < 0.001), physical function (r = -0.510, p < 0.001), and role limitation-physical dimensions (r = -0.505, p < 0.001). Moreover, digestive, pulmonary, and overall disease severity VASs were statistically significantly correlated to the number of organs involved (r = 0.178, p = 0.029; r = 0.214, p = 0.008; r = 0.282, p < 0.001). We also demonstrated high reproducibility for SHAQ (ICC = 0.757, 95 % confidence interval = 0.636-0.842). The Brazilian version of the SHAQ demonstrated both construct and discriminant validities as well as good reproducibility.

摘要

硬皮病健康评估问卷(SHAQ)是一种可行的多系统特异性工具,已被广泛用作系统性硬化症(SSc)的附加评估工具。本研究的目的是对巴西版SHAQ进行跨文化调适和验证。基于SHAQ与医学结局调查简表36第2版(SF - 36v2™)以及健康评估问卷残疾指数(HAQ - DI)之间的相关性评估结构效度。通过Spearman相关系数评估SHAQ与疾病严重程度之间的相关性。通过组内相关系数(ICC)评估SHAQ的可重复性。在连续评估的151名门诊患者中,59%为局限性硬皮病亚型。SHAQ的总体疾病严重程度视觉模拟量表(VAS)与HAQ - DI、疼痛VAS以及SF - 36v2™身体成分汇总得分在统计学上显著相关(分别为r = 0.595、r = 0.612和r = -0.582;p < 0.001)。对所有SF - 36v2™成分的进一步分析显示,总体疾病严重程度VAS与身体疼痛(r = -0.621,p < 0.001)、活力(r = -0.544,p < 0.001)、身体功能(r = -0.510,p < 0.001)以及角色限制 - 身体维度(r = -0.505,p < 0.001)之间存在统计学显著相关性。此外,消化系统、肺部和总体疾病严重程度VAS与受累器官数量在统计学上显著相关(r = 0.178,p = 0.029;r = 0.214,p = 0.008;r = 0.282,p < 0.001)。我们还证明了SHAQ具有高可重复性(ICC = 0.757,95%置信区间 = 0.636 - 0.842)。巴西版SHAQ显示出结构效度和区分效度以及良好的可重复性。

相似文献

1
Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).硬皮病健康评估问卷(SHAQ)巴西版的跨文化调适与验证
Clin Rheumatol. 2014 May;33(5):699-706. doi: 10.1007/s10067-013-2370-8. Epub 2013 Aug 22.
2
Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.验证土耳其版硬皮病生活质量评估问卷。
Clin Rheumatol. 2019 Jul;38(7):1917-1923. doi: 10.1007/s10067-019-04494-5. Epub 2019 Mar 6.
3
Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.验证系统性硬皮病健康评估问卷的葡萄牙语版本。
Int J Environ Res Public Health. 2023 Nov 14;20(22):7062. doi: 10.3390/ijerph20227062.
4
Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.评估系统性硬化症患者的残疾情况和生活质量:科钦手功能量表、健康评估问卷(HAQ)、系统性硬化症HAQ及医学结局研究36项简短健康调查的结构效度。
Arthritis Rheum. 2007 Feb 15;57(1):94-102. doi: 10.1002/art.22468.
5
Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ).硬皮病健康评估问卷(SHAQ)波斯语版本的翻译与验证
Intern Emerg Med. 2023 Apr;18(3):811-819. doi: 10.1007/s11739-023-03229-4. Epub 2023 Feb 28.
6
Translation and cross-cultural adaptation of the Scleroderma Health Assessment Questionnaire to Brazilian Portuguese.《硬皮病健康评估问卷》翻译成巴西葡萄牙语及跨文化调适
Sao Paulo Med J. 2014;132(3):163-9. doi: 10.1590/1516-3180.2014.1323621. Epub 2014 Apr 28.
7
Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.评价系统性硬化症患者的健康评估问卷和生活质量的中英文版本。
Int J Rheum Dis. 2012 Jun;15(3):268-76. doi: 10.1111/j.1756-185X.2012.01731.x. Epub 2012 Apr 29.
8
Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.系统性硬化症患者中文版 Scleroderma Health Assessment Questionnaire 和 Cochin 手功能量表的心理测量特性。
Scand J Rheumatol. 2013;42(4):317-24. doi: 10.3109/03009742.2012.756928. Epub 2013 Feb 27.
9
Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).硬皮病健康评估问卷(SSc HAQ)法语版的验证
Clin Rheumatol. 2005 Feb;24(1):3-10. doi: 10.1007/s10067-004-0942-3. Epub 2004 Jun 23.
10
The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties.硬皮病试验中的健康评估问卷残疾指数和硬皮病健康评估问卷:对其测量属性的评估
Arthritis Rheum. 2005 Apr 15;53(2):256-62. doi: 10.1002/art.21084.

引用本文的文献

1
Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire.系统性硬化症健康评估问卷泰语版的验证与跨文化调适
Clin Rheumatol. 2025 Jul 1. doi: 10.1007/s10067-025-07553-2.
2
Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.验证系统性硬皮病健康评估问卷的葡萄牙语版本。
Int J Environ Res Public Health. 2023 Nov 14;20(22):7062. doi: 10.3390/ijerph20227062.
3
Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ).

本文引用的文献

1
Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).系统性硬化症(硬皮病)的测量指标:健康评估问卷(HAQ)和硬皮病HAQ(SHAQ)、医生和患者评定的整体评估、症状负担指数(SBI)、加利福尼亚大学洛杉矶分校硬皮病临床试验协作组胃肠道量表(UCLA SCTC GIT)2.0、基线呼吸困难指数(BDI)和过渡性呼吸困难指数(TDI)(马勒指数)、剑桥肺动脉高压结果评估(CAMPHOR)以及雷诺病情评分(RCS)。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S98-111. doi: 10.1002/acr.20598.
2
Validation of new biomarkers in systemic autoimmune diseases.系统性自身免疫性疾病中新生物标志物的验证。
Nat Rev Rheumatol. 2011 Nov 1;7(12):708-17. doi: 10.1038/nrrheum.2011.157.
硬皮病健康评估问卷(SHAQ)波斯语版本的翻译与验证
Intern Emerg Med. 2023 Apr;18(3):811-819. doi: 10.1007/s11739-023-03229-4. Epub 2023 Feb 28.
4
Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.验证土耳其版硬皮病生活质量评估问卷。
Clin Rheumatol. 2019 Jul;38(7):1917-1923. doi: 10.1007/s10067-019-04494-5. Epub 2019 Mar 6.
3
Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensões Sociais das Desigualdades (PDSD), Brazil, 2008.SF-36(v.2)问卷在巴西家庭概率样本中的心理计量学评估:巴西社会不平等维度调查(PDSD)的调查结果,2008 年。
Health Qual Life Outcomes. 2011 Aug 3;9:61. doi: 10.1186/1477-7525-9-61.
4
Targeted therapy for systemic sclerosis: how close are we?系统性硬皮病的靶向治疗:我们离目标还有多远?
Nat Rev Rheumatol. 2010 May;6(5):269-78. doi: 10.1038/nrrheum.2010.48. Epub 2010 Apr 13.
5
Health-related quality of life in systemic sclerosis: a systematic review.系统性硬化症患者的健康相关生活质量:一项系统综述。
Arthritis Rheum. 2009 Aug 15;61(8):1112-20. doi: 10.1002/art.24676.
6
Clinical correlates of self-reported physical health status in systemic sclerosis.系统性硬化症患者自我报告的身体健康状况的临床相关性
J Rheumatol. 2009 Jun;36(6):1226-9. doi: 10.3899/jrheum.081057. Epub 2009 May 15.
7
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.硬皮病胃肠道1.0版生活质量初步量表的研制。
Arthritis Rheum. 2007 Oct 15;57(7):1280-6. doi: 10.1002/art.22987.
8
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.口服环磷酰胺对活动性硬皮病肺病患者健康相关生活质量的影响:硬皮病肺病研究结果
Arthritis Rheum. 2007 May;56(5):1676-84. doi: 10.1002/art.22580.
9
Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.评估系统性硬化症患者的残疾情况和生活质量:科钦手功能量表、健康评估问卷(HAQ)、系统性硬化症HAQ及医学结局研究36项简短健康调查的结构效度。
Arthritis Rheum. 2007 Feb 15;57(1):94-102. doi: 10.1002/art.22468.
10
Quality criteria were proposed for measurement properties of health status questionnaires.针对健康状况调查问卷的测量属性提出了质量标准。
J Clin Epidemiol. 2007 Jan;60(1):34-42. doi: 10.1016/j.jclinepi.2006.03.012. Epub 2006 Aug 24.